HIV levels fell in HSV-2–seronegative patients taking valacyclovir
HIV levels declined in patients who did not have herpes but took the antiherpes drug valacylovir in a double-blind placebo-controlled crossover trial.
The study showed that the drug “likely reduced HIV levels by interfering directly with HIV’s reproductive machinery and did not require the...
Source: Skin and Allergy News - Category: Dermatology Tags: IMN Journals IMN News IMN Infectious Diseases FPN Journals FPN News FPN Infectious Diseases Source Type: news
More News: Allergy | Allergy & Immunology | Dermatology | Herpes | Infectious Diseases | Skin | Study | Valtrex